Literature DB >> 23707617

Uric acid induces oxidative stress and growth inhibition by activating adenosine monophosphate-activated protein kinase and extracellular signal-regulated kinase signal pathways in pancreatic β cells.

Yongneng Zhang1, Tetsuya Yamamoto, Ichiro Hisatome, Youfeng Li, Weijie Cheng, Ning Sun, Bozhi Cai, Tianliang Huang, Yuzhang Zhu, Zhi Li, Xubin Jing, Rui Zhou, Jidong Cheng.   

Abstract

Hyperuricaemia is a disorder of purine metabolism, and is strongly associated with insulin resistance and abnormal glucose metabolism. As the producer of insulin, pancreatic β cells might be affected by elevated serum uric acid levels and contribute to the disregulated glucose metabolism. In this study, we investigated the effect of high uric acid on rat pancreatic β cell function. Under high uric acid condition, proliferation of pancreatic β cells was inhibited, production of reactive oxygen species increased, and glucose stimulated insulin secretion was also compromised. Further examination on signal transduction pathways revealed that uric acid-induced ROS is involved in the activation of adenosine monophosphate-activated protein kinase (AMPK), and extracellular signal-regulated kinase (ERK). Pharmacological inhibition of ERK activation rescued β cells from growth inhibition. More importantly, activation of ERK induced by uric acid is significantly diminished by AMPK inhibitor, indicating ERK as a downstream target of AMPK in response to high uric acid condition. We also investigated the transportation channel for uric acid into pancreatic β cells. While major urate transporter URAT1 is not expressed in β cells, organic anion transporter (OAT) inhibitor successfully blocked the activation of ERK by uric acid. Our data indicate that high uric acid levels induce oxidative damage and inhibit growth of rat pancreatic β cells by activating the AMPK and ERK signal pathways. Hyperuricemia may contribute to abnormal glucose metabolism by causing oxidative damage and function inhibition of pancreatic β cells.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23707617     DOI: 10.1016/j.mce.2013.04.027

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  44 in total

Review 1.  A novel mutation in gene of PRPS1 in a young Chinese woman with X-linked gout: a case report and review of the literature.

Authors:  Bo-Yun Yang; Han-Xiao Yu; Jie Min; Xiao-Xiao Song
Journal:  Clin Rheumatol       Date:  2019-11-26       Impact factor: 2.980

Review 2.  Roles of hyperuricemia in metabolic syndrome and cardiac-kidney-vascular system diseases.

Authors:  Hongsha Wang; Haifeng Zhang; Lin Sun; Weiying Guo
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

3.  Evidence for the effect of soluble uric acid in augmenting endoplasmic reticulum stress markers in human peripheral blood mononuclear cells.

Authors:  Reyhane Ebrahimi; Parvin Pasalar; Hajar Shokri; Maryam Shabani; Solaleh Emamgholipour
Journal:  J Physiol Biochem       Date:  2022-01-05       Impact factor: 4.158

4.  Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets.

Authors:  Limei Liu; Jian Liu; Yuansheng Gao; Xiaoxing Yu; Gang Xu; Yu Huang
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

5.  Serum uric acid levels are associated with homeostasis model assessment in obese nondiabetic patients: HOMA and uric acid.

Authors:  Cesar I Elizalde-Barrera; Teresa Estrada-García; Jose J Lozano-Nuevo; Ana K Garro-Almendaro; Catalina López-Saucedo; Alberto F Rubio-Guerra
Journal:  Ther Adv Endocrinol Metab       Date:  2017-10-11       Impact factor: 3.565

Review 6.  Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back.

Authors:  Chengfu Xu
Journal:  Hepatol Int       Date:  2015-12-15       Impact factor: 6.047

7.  Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway.

Authors:  Tania O Crişan; Maartje C P Cleophas; Boris Novakovic; Kathrin Erler; Frank L van de Veerdonk; Hendrik G Stunnenberg; Mihai G Netea; Charles A Dinarello; Leo A B Joosten
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

Review 8.  MicroRNAs and Oxidative Stress: An Intriguing Crosstalk to Be Exploited in the Management of Type 2 Diabetes.

Authors:  Teresa Vezza; Aranzazu M de Marañón; Francisco Canet; Pedro Díaz-Pozo; Miguel Marti; Pilar D'Ocon; Nadezda Apostolova; Milagros Rocha; Víctor M Víctor
Journal:  Antioxidants (Basel)       Date:  2021-05-19

9.  Metformin protects against insulin resistance induced by high uric acid in cardiomyocytes via AMPK signalling pathways in vitro and in vivo.

Authors:  Zhenyu Jiao; Yingqun Chen; Yang Xie; Yanbing Li; Zhi Li
Journal:  J Cell Mol Med       Date:  2021-05-30       Impact factor: 5.310

10.  Sitagliptin on carotid intima-media thickness in type 2 diabetes and hyperuricemia patients: a subgroup analysis of the PROLOGUE study.

Authors:  Yipin Zhao; Huawei Wang; Dazhi Ke; Wei Deng; Yingying Ji; Jiaojiao Yang; Zebin Lin; Guoxing Li; Li Xiao; Jianmin Tang; Qingwei Chen
Journal:  Ther Adv Chronic Dis       Date:  2021-06-22       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.